J9150
J9150 – Injection, daunorubicin, 10 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 9 NDCs crosswalked per 10 MG $28.810/unit ASP+6%
📋 J9150 summary
J9150 is a HCPCS Level II J-code used to bill daunorubicin, 10 mg, billed per 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J9150: Daunorubicin Hydrochloride
Code J9150
Billing unit 10 MG Payment limit $28.810/unit NDC-Crosswalk 9
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ9150
DescriptorInjection, daunorubicin, 10 mg
Billing unit10 MG
Payment limit / unit$28.810
Est. ASP / unit$27.179 est.
Mapped NDCs9
Data periodQ3 2026
Last updated2026-08-20
💊 About Daunorubicin DRUG GUIDE
Daunorubicin Hydrochloride Injection is used to help bring about remission — meaning a significant reduction or disappearance of leukemia cells — in people with certain types of leukemia.
It is always given in combination with other approved anticancer drugs, not alone.Specifically, it is approved for remission induction in acute nonlymphocytic leukemia (including the myelogenous, monocytic, and erythroid subtypes) in adults, and for remission induction in acute lymphocytic leukemia in both children and adults.
Clinical overview from our editorial drug guide for Daunorubicin. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$28.810
Est. ASP / unit
$27.179 est.
Est. after 2% sequester
$28.234
HCPCS dosage
10 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, daunorubicin, 10 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment groupYY
Action codeN — No maintenance this year
Effective date2009-01-01
Date added1986-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J9150 = 10 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J9150 WITH EST. MEDICARE PAY
9 NDCs map to J9150. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($28.810/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00143-9550-01 | Daunorubicin Hydrochloride 5 mg/mL INJECTION | Hikma | 1 VIAL in 1 CARTON (0143-9550-01) / 10 mL... | 5 mg/mL | 5 | $144.05 | — | ● Active | CMS ASP |
| 00143-9551-10 | Daunorubicin Hydrochloride 5 mg/mL INJECTION | Hikma | 10 VIAL in 1 BOX (0143-9551-10) / 4 mL in... | 5 mg/mL | 20 | $576.20 | — | ● Active | CMS + PDAC |
| 42658-0019-01 | Daunorubicin Hydrochloride 5 mg/mL INJECTION, SOLUTION | Hisun | 1 VIAL in 1 BOX (42658-019-01) / 10 mL in... | 5 mg/mL | 5 | $144.05 | — | ● Active | CMS + PDAC |
| 42658-0021-01 | Daunorubicin Hydrochloride 5 mg/mL INJECTION, SOLUTION | Hisun | 1 VIAL in 1 BOX (42658-021-01) / 4 mL in... | 5 mg/mL | 2 | $57.62 | — | ● Active | CMS + PDAC |
| 42658-0021-02 | Daunorubicin Hydrochloride 5 mg/mL INJECTION, SOLUTION | Hisun | 10 VIAL in 1 CARTON (42658-021-02) / 4 mL... | 5 mg/mL | 20 | $576.20 | — | ● Active | CMS + PDAC |
| 42658-0021-91 | Daunorubicin Hydrochloride 5 mg/mL INJECTION, SOLUTION | Hisun | 1 VIAL in 1 BOX (42658-021-91) / 4 mL in... | 5 mg/mL | 2 | $57.62 | — | ● Active | CMS + PDAC |
| 42658-0021-92 | Daunorubicin Hydrochloride 5 mg/mL INJECTION, SOLUTION | Hisun | 10 VIAL in 1 CARTON (42658-021-92) / 4 mL... | 5 mg/mL | 20 | $576.20 | — | ● Active | CMS + PDAC |
| 71288-0182-05 | daunorubicin hydrochloride 5 mg/mL INJECTION, SOLUTION | Meitheal | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-18... | 5 mg/mL | 20 | $576.20 | — | ● Active | CMS + PDAC |
| 00703-5233-13 | DAUNORUBICIN HCL (S.D.V.,PF) 5 MG/ML | Unknown | — | — | 0.5 | $14.41 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2025 (Q1-Q4)
Total Part B spend
$2.7K
Claims
17
Beneficiaries
—
Spend / beneficiary
—
Spend / claim
$158.39
Where J9150 ranks among Part B drugs · 2025 (Q1-Q4) · neighbors ±5
Total spending — #857 of 918
#852
CIPROFLOXACIN-D5W J0744
$3.6K
#853
VANCOMYCIN HCL(J3374... J3374
$3.5K
#854
HYDROXYZINE HCL J3410
$3.2K
#855
NITROGLYCERIN IN D5W... J2305
$3.2K
#856
FLUPHENAZINE HCL J2679
$2.9K
#857
DAUNORUBICIN HCL J9150
$2.7K
#858
CANCIDAS* J0637
$2.6K
#859
PROTAMINE SULFATE J2720
$2.5K
#860
RHOPHYLAC J2791
$2.4K
#861
LINEZOLID-D5W* J2020
$2.2K
#862
METHOTREXATE* J8610
$2.2K
Total claims — #901 of 918
#896
DECITABINE J0893
18
#897
VANCOMYCIN HCL(J3372... J3372
18
#898
CEFEPIME-DEXTROSE J0703
17
#899
OCTREOTIDE ACETATE* J2354
17
#900
VANCOMYCIN HCL(J3371... J3371
17
#901
DAUNORUBICIN HCL J9150
17
#902
SURGRAFT FT PER SQ C... Q4268
17
#903
DIGIFAB J1162
16
#904
ARISTADA INITIO J1943
16
#905
VASOPRESSIN* J2598
16
#906
GRAFIX CORE, GRAFIXP... Q4132
16
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (1)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2025 (Q1-Q4) | $2.7K | — | 17 | — | $158.39 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$633.52
Medicare paid
$1.1K
Submitted services
24
Submitted charges
$2K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J9150
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
9 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2025
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J9150 billing FAQ
What is HCPCS code J9150?
J9150 is a HCPCS Level II J-code used to bill Injection, daunorubicin, 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J9150?
One unit of J9150 represents 10 MG. Report the number of units equal to the dose administered divided by 10 MG.
How many units of J9150 should I bill?
Divide the dose administered by the code's unit size (10 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J9150?
The Medicare Part B payment limit is $28.810 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $28.234 per unit. Payment limits are revised quarterly.
Which NDCs bill under J9150?
9 NDCs currently map to J9150 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9150 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.